Endologix hits primary endpoints in one-year follow-up data for DETOUR2 trial
Endologix has reported positive one-year results from its DETOUR2 trial evaluating its fully percutaneous transmural arterial bypass therapy. The prospective, single-arm, multi-centre, international trial enrolled 202 patients with long-segment superficial …